Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carla Indennidate"'
Autor:
Giulia Barbati, Caterina Gregorio, Arjuna Scagnetto, Carla Indennidate, Chiara Cappelletto, Andrea Di Lenarda
Publikováno v:
PLoS ONE, Vol 19, Iss 8, p e0309470 (2024)
Low-Density Lipoprotein (LDL) cholesterol is one of the main target for cardiovascular (CV) prevention and therapy. In the last years, Proprotein Convertase Subtilisin-Kexin type 9 inhibitors (PCSK9-i) has emerged as a key therapeutic target to lower
Externí odkaz:
https://doaj.org/article/0edbc88617fa4bdaabf660df58faa2b0
Publikováno v:
European Heart Journal Supplements. 25:B69-B74
Left ventricular (LV) systolic function is an essential parameter for the evaluation of patients with ischaemic heart disease, and therapeutic choices are significantly driven by LV ejection fraction (LVEF) in the early stage of the disease and durin
Publikováno v:
European Heart Journal Supplements. 24
Background The association between chronic neuropathic pain in childhood, left ventricular hypertrophy(LVH), early ischemic stroke and unexplained renal failure is suggestive of FD. However, because of the heterogeneity of the genetic substrate, diff
Autor:
Francesco Antonio Veneziano, Ilaria Cavallari, Francesco Grigioni, Dario Tuccinardi, Ernesto Maddaloni, Carla Indennidate, Silvia Pieralice, Nicola Napoli, Raffaella Buzzetti
Publikováno v:
European Heart Journal Supplements. 24
Effects of novel glucose-lowering agents on cardiac autonomic function and structure in type 2 diabetes Ilaria Cavallari, Ernesto Maddaloni, Francesco Veneziano, Carla Indennidate, Maria Valeria Giaccari, Dario Tuccinardi, Silvia Pieralice, Nicola Na